The Skin Cancer Drugs Clinical Pipeline 2019​


​Release Date: Q3' 2019
Number of Candidates: 138

Synopsis: Skin cancer, the uncontrolled growth of abnormal skin cells, is among the most common types of cancer. With the exception of melanoma, most skin cancers are not life threatening. However, early diagnosis and treatment are critical to avoid functional or cosmetic deformities that can result from the invasion and damage of nearby tissues and organs. 

Although surgery is the most common treatment for skin cancer, drugs – including chemotherapy, immunotherapy and targeted agents – are widely used for treating advanced forms of skin cancer. Drug developers are investing heavily in new drug development programs for skin cancer, primarily in the areas of melanoma, BCC (Basal Cell Carcinoma) and SCC (Squamous Cell Carcinoma), with several promising candidates in the late stages of the clinical pipeline.
The “Skin Cancer Drugs Pipeline 2020” excel sheet presents a look at the major drug candidates currently in the clinical pipeline.

The data-set is delivered in an Excel sheet covering clinical drug development pipeline for the skin cancer drugs market, profiling 138 future candidates.

For a Sample and Inquiries please contact info@snsintel.com

Pricing: The pipeline excel data sheet is available for the following price: 
​
Single User License: USD 1000

Company Wide License (Single Site): USD 1,500

Company Wide License (Global Site): USD 2,500

Pipeline Candidates Data Segmentation:
Drug pipeline data set offers a breakdown in the following subcategories:
  • Candidate (Name)
  • Drug Developer(s)
  • Indication/Therapeutic Area(s)​
    • Actinic Keratosis
    • BCC (Basal Cell Carcinoma)
    • CTCL (Cutaneous T-Cell Lymphoma)
    • Kaposi's Sarcoma
    • MCC (Merkel Cell Carcinoma)
    • Melanoma
    • Multiple Skin Cancers
    • SCC (Squamous Cell Carcinoma)
    • Soft Tissue Sarcoma
  • Classification(s)
    • Combination Therapy
    • Gene & Cell Therapy
    • Monoclonal Antibody 
    • Small Molecule
    • Virus & Vaccine
    • Others
  • Phase
    • Pre-Clinical
    • ​Phase I
    • Phase I/II
    • Phase II
    • Phase II/III
    • Phase III
    • Pre-Registration​

List of Companies Mentioned:
The following companies and organizations have been mentioned in the pipeline:

Altor BioScience
AB Science 
AbbVie
Adaptimmune
Adgero Biopharmaceuticals
Agenus
Altor BioScience
Amgen
Angimmune
APCure
Apexigen
Array BioPharma
Ascend Biopharmaceuticals
AstraZeneca
Athenex
Autotelic
Basilea Pharmaceutica
Berg
BioLineRx
Bioniz
Biosceptre
Biothera
BMS (Bristol-Myers Squibb)
Boehringer Ingelheim
Boston Biomedical
Brickell Biotech
BrightPath Biotherapeutics
Celgene
Celldex Therapeutics
CEL-SCI Corporation
Checkmate Pharmaceuticals
Cutanea Life Sciences
Cytori Therapeutics
CytRx Corporation
Daiichi Sankyo (Plexxikon)
DFB Soria LLC
Dr. Reddy’s Laboratories 
Dynavax Technologies
Eisai (Morphotek)
Elios Therapeutics
Exelixis
G&E Herbal Biotechnology
Galderma
Galectin Therapeutics
Genentech (Roche)
Glycotope
GSK (GlaxoSmithKline)
HedgePath Pharmaceuticals
Huya Bioscience
Idera Pharmaceuticals
Immune Design
Immunocore
Incyte Corporation
Infinity Pharmaceuticals
Innate Pharma
Inovio
Inovio Pharmaceutical
Iovance Biotherapeutics
Ipsen
IRX Therapeutics
Jiangsu Hengrui Medicine Co
Karyopharm Therapeutics
Kowa
Leap Therapeutics
LEO Pharma
Lilly
LSK BioPharma
MacroGenics
MedImmune
Medivir
Merck
Merck & Co.
Merck KGaA
miRagen Therapeutics
Mirati Therapeutics
Moderna Therapeutics
Molecular Templates
NanoCarrier
Nanology
NantCell
NantKwest
Nektar Therapeutics
Neon Therapeutics
Neumedicines
NewLink Genetics
Novartis
Oncolys Biopharma
Oncolytics Biotech
Oncosec Medical
Oncotelic
Ono Pharmaceutical
PellePharm
Pfizer
Philogen
Phio Pharmaceuticals
Polaris Pharmaceuticals
Polynoma
Provectus Biopharmaceuticals 
Reata Pharmaceuticals
Regeneron Pharmaceutical
Rhizen Pharmaceuticals
Roche (Ignyta)
Sanofi
Sanofi (Genzyme Corporation)
Sesen Bio
Soligenix
Sumitomo Dainippon Pharma
Syndax Pharmaceuticals
Takara Bio
Takeda
Takeda Oncology (Millennium Pharmaceuticals)
Targovax
Transgene
Trillium Therapeutics
Ultimovacs
Vidac Pharma
Viralytics
X4 Pharmaceuticals